bibliographicCitation |
Goodin S, Rao KV, Kane M, Dave N, Capanna T, Doyle-Lindrud S, Engle E, Jin L, Todd M, DiPaola RS. A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer. Cancer Chemother Pharmacol. 2005 Aug;56(2):199–204. doi: 10.1007/s00280-004-0980-1. PMID: 15838657. |